KBPA-103

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameKBPA-103
Drug Alias Namehuman MAb (Kenta Biotech)human monoclonal antibody (Kenta Biotech)KBPA-103
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionLipopolysaccharide (LPS) modulators
TargetsLipopolysaccharide (LPS)
Therapy Area/IndicationsPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKenta Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKenta Biotech Ltd
Active IndicationsN/A
Inactive IndicationsPseudomonas Infections

Other Information

ATC CodeN/A
Related LinksN/A